Each NeuroPI module is prepared by distinguished faculty who are acknowledged leaders in their respective fields. Each module is composed of a set of multiple-choice items with preferred response, instructions on how to collect cases to assess one's practice, and resources for creating and implementing an effective improvement plan. Participants are able to compare their performance pre- and post intervention to assess what changes have occurred in their practice.
Members: FREE $199.00*
*Free access is limited to one course at a time for eligible members.
- Recognize the need to document seizure frequency and discuss change in therapy, if appropriate, in patients diagnosed with epilepsy.
- Identify the need to determine etiology of epilepsy, seizure type or epilepsy syndrome in patients diagnosed with epilepsy.
- Recognize the need to query about and discuss side effects of anti-seizure therapy with patients diagnosed with epilepsy.
- Describe the need for personalized epilepsy safety issues and patient education annually for all patients diagnosed with epilepsy.
- Explain the need to screen patients diagnosed with epilepsy for psychiatric or behavioral disorders.
- Recognize the need to counsel women of diagnosed with epilepsy of childbearing potential on how epilepsy and its treatment may affect contraception or pregnancy.
Category 1: Patients with a Diagnosis of Epilepsy
- Querying for seizure frequency AND discussion of change in therapy.
- Etiology, Seizure Type, or Epilepsy Syndrome.
- Querying and Intervention for Side Effects of Anti-seizure Therapy.
- Personalized Epilepsy Safety Issues and Education Provided.
- Screening for Psychiatric or Behavioral Health Disorders.
- Counseling for Women of Childbearing Potential with Epilepsy.
As a result of this program, the participant will determine individual practice gaps and address them through a performance improvement plan designed to improve competence, performance, and patient outcomes.
Epilepsy is a widely recognized neurologic condition, but it is often poorly understood, diagnosed, and treated. The quality measures applied within this program seek to increase patient safety, improve diagnosis, improve treatment, reduce the number of deaths due to epilepsy, and increase the quality of life for those who have epilepsy.
- Interpersonal Skills and Communication
- Medical Knowledge
- Patient Care
- Practice-based Learning and Improvement
Date of Release
May 31, 2017
This module is eligible for CME credits for three years from the release date.
NeuroPI Data Terms & Conditions
The American Academy of Neurology Institute (AANI) no longer requires You (NeuroPI and aan.com user) to provide full date of service (day/month/year); only year of service will be transmitted to and stored by AANI. All previously collected "day" and "month" from date of service records have been deleted from the AANI's NeuroPI database. Accordingly, for NeuroPI, AANI is not requesting or storing any "protected health information" or "limited data sets" as defined by the regulations issued under the Health Insurance Portability and Accountability Act of 1996. The patient data You submit to the AANI through NeuroPI is de-identified health information. You must track patients separately from NeuroPI. Within the NeuroPI modules, Your patients will be identified using a 4-digit patient code that You create. Any other identifying information is strictly prohibited. Please use the NeuroPI Patient Tracker to create Your 4-digit patient codes for Your personal reference. The NeuroPI Patient Tracker must not be shared with AANI.
The American Academy of Neurology Institute either owns or has permission to use all of the NeuroPI module content. You may use these modules for your personal, noncommercial use, but please send permissions requests for any other uses to NeuroPI@aan.com. All of the individual de-identified health information you submit to the AANI through NeuroPI is confidential. Your maintenance of certification ("MOC") credit information is transmitted to the American Board of Psychiatry and Neurology (ABPN) once You've completed a module. You can opt-out of this service in NeuroTracker. Please note, AANI is not a certifying board and members are encouraged to contact ABPN for the most up-to-date information on MOC requirements. You acknowledge that AANI is and shall be deemed the owner of all rights to the aggregate, de-identified data submitted to NeuroPI and subsets of the aggregate data, any and all reports based on the aggregate, de-identified data, and all trademarks and trade secrets arising from or reflected in NeuroPI (collectively, "Aggregate Data"), with the exception of your individual data. AANI has full and unencumbered rights to publish, disclose, distribute, market, sell, and create derivatives of, Aggregate Data in any form.
JOSEPH I. SIRVEN, MD, CHAIR
Professor and Chairman, Department of Neurology, Mayo Clinic
*Dr. Sirven has received personal compensation for activities with UCB, Inc., Acadia, and Upsher-Smith as a consultant. Dr. Sirven has received research support from Neuropace Inc.
KATHERINE H. NOE, MD, PhD, FAAN
Neurologist, Mayo Clinic
*Dr. Noe has received research support from NeuroPace.
DONALD J. IVERSON, MD, FAAN
Humboldt Neurological Medical Group
*Dr. Iverson has nothing to disclose.
DON B. SMITH, MD, FAAN
*Dr. Smith has received personal compensation for activities with Penumbra, Inc., as a speaker.
*Ms. Chamberlain has nothing to disclose.
+ Unlabeled Use of Products/Investigational Use Disclosure